Rights and permissions
About this article
Cite this article
Risperidone cost advantage over olanzapine in schizophrenia. Pharmacoecon. Outcomes News 328, 3 (2001). https://doi.org/10.1007/BF03280507
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280507